Showing results (271-280 of 290) with videos related to

Sort By:
Pageof 29
The Journal of Clinical Investigation|July 24, 2025
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and non-respondersGuokun Zhang, Vindi Jurinovic, Stephan Bartels, et al.
Leukemia|May 3, 2020
Clinical presentation and differential splicing of SRSF2, U2AF1 and SF3B1 mutations in patients with acute myeloid leukemiaStefanos A Bamopoulos, Aarif M N Batcha, Vindi Jurinovic, et al.
Clinical and Translational Radiation Oncology|May 20, 2024
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)Sebastian H Maier, Stephan Schönecker, Vasiliki Anagnostatou, et al.
The Lancet. Neurology|July 7, 2019
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJohannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.
European Stroke Journal|April 6, 2023
The EffecTs of Amlodipine and other Blood PREssure Lowering Agents on Microvascular FuncTion in Small Vessel Diseases (TREAT-SVDs) trial: Study protocol for a randomised crossover trialAnna Kopczak, Michael S Stringer, Hilde van den Brink, et al.
Haematologica|December 16, 2017
A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemiaTobias Herold, Vindi Jurinovic, Aarif M N Batcha, et al.
Blood|June 14, 2014
Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosisTobias Herold, Klaus H Metzeler, Sebastian Vosberg, et al.
Lancet (London, England)|July 6, 2023
Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trialGerrit Burkhardt, Ulrike Kumpf, Alexander Crispin, et al.
Trials|September 12, 2018
Effect of a combined brief narrative exposure therapy with case management versus treatment as usual in primary care for patients with traumatic stress sequelae following intensive care medicine: study protocol for a multicenter randomized controlled trial (PICTURE)Jochen Gensichen, Susanne Schultz, Christine Adrion, et al.
The Lancet. Neurology|October 20, 2023
Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trialAnna Kopczak, Michael S Stringer, Hilde van den Brink, et al.
Pageof 29